SOPHARMA AD - Notification for acquisition of own shares
Aktualizacja:
23.09.2020 11:44
Publikacja:
23.09.2020 11:44
| POLISH FINANCIAL SUPERVISION AUTHORITY | |
| | | UNI - EN REPORT No | 102 | / | 2020 | | |
| Date of issue: | 2020-09-23 | | | | | | | | |
| Short name of the issuer | | | | | | | |
| SOPHARMA AD | |
| Subject | | | | | | | | | | |
| Notification for acquisition of own shares | |
| Official market - legal basis | | | | | | |
| art. 56. 1. 2 of Act on Public Offering. | |
| Unofficial market - legal basis | | | | | |
| Contents of the report: | | | | | | | | |
| Sofia, Bulgaria, September 23, 2020 - According to art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on September 21, 2020 the Company sold 9 000 own shares representing 0.0067% of the share capital of the Company, at a total value of BGN 28 260 on the Bulgarian Stock Exchange, the average price per share was 3.1400 BGN. The total number of treasury shares after this transaction is 8 965 467, representing 6.651% of the share capital of the Company. | |
| Annexes | | | | | | | | | | |
| File | Description | |
| Current report_102_buy back_espi.pdf | Notification for acquisition of own shares | |
| | SOPHARMA AD | | |
| | (fullname of the issuer) | | |
| | SOPHARMA AD | | Farmaceutyczny (far) | | |
| | (short name of the issuer) | | (sector according to clasification of the WSE in Warsow) | | |
| | 1220 | | Sofia | | |
| | (post code) | | (city) | | |
| | IlienskoShosse | | 16 | | |
| | (street) | | (number) | | |
| | +359 2 813 42 00 | | +359 2 936 02 86 | | |
| | (phone number) | | | (fax) | | |
| | (e-mail) | | | (web site) | | |
| | nd | | | | |
| | (NIP) | | | (REGON) | | |
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |
| Date | Name | Position / Function | Signature | |
| 2020-09-23 | Ognian Donev | Executive Director | | |
Current report_102_buy back_espi.pdf
